Number of people living with MS across the world surpasses 3 million for the first time

The Atlas of MS estimates 3.1 million people are now living with MS worldwide.

Mejorar la concientización de esclerosis múltiple en África con jóvenes neurólogos a la cabeza

MSIF Du Pré grants support the development of MS healthcare expertise

Improve MS diagnosis

Many people with MS experience delays in diagnosis and are often misdiagnosed. Consider what can be done to improve awareness and improve early diagnosis.

Earlier diagnosis requires more than new criteria

New open-access paper explores how the updated McDonald criteria can support earlier diagnosis worldwide and highlights the importance of ensuring healthcare systems are equipped to translate these advances into better outcomes for people with MS.

Global gaps in MS diagnostic testing risk delaying diagnosis for many

New research highlights inequalities in access to key tests needed for early MS diagnosis and the urgent need to close these gaps as diagnostic criteria evolve.

Free online course to help improve MS diagnosis

Support this World MS Day initiative

Understanding the updated McDonald criteria for diagnosing MS

What you need to know

Nueva campaña del Día Mundial de la Esclerosis Múltiple

Diagnosis theme for World MS Day 2024-2025

¿Es esclerosis múltiple u otra cosa?

Global MS experts update recommendations for the differential diagnosis of MS

Global barriers to MS diagnosis

Importance of training and education for healthcare professionals is highlighted in new publication

Brújula EM de Uruguay

Esclerosis Múltiple Uruguay creates a digital tool to help people understand and live better with MS.

Diagnóstico: hacerlo pronto y bien

Diagnosis of MS is getting faster and more efficient but new research suggests there are still ways to improve diagnosis

Los síntomas de la EM pueden comenzar cinco años antes del diagnóstico

Canadian research shows people with MS are more likely than the general population to visit a doctor or hospital in the years leading up to an MS diagnosis.

Reajustar el diagnóstico en las personas con EM

Expert panel publishes revised criteria for MS diagnosis

Un nuevo biomarcador potencial para el diagnóstico de la EM

A new small study has discovered molecules in the blood that are specific to people with MS, and can distinguish between relapsing remitting and progressive MS.

El director ejecutivo de MS Research Australia celebra el importante papel de las nuevas tecnologías para transformar la vida de las personas que tienen esclerosis múltiple

Matthew Miles, Chief Executive of MS Research Australia, shared insights on how technology is revolutionising research, treatment, diagnosis, and more

EM Irlanda actúa

MS Ireland launches two major new publications on early treatment and diagnosis of MS

Diagnóstico

Neurologists typically carry out several tests to find out whether someone has MS.